Resolution of risperidone-induced hyperprolactinemia with substitution of quetiapineARUN RAJ KUNWAR; MEGNA, James L.The Annals of pharmacotherapy. 2003, Vol 37, Num 2, pp 206-208, issn 1060-0280, 3 p.Article

Clinical trial response and dropout rates with olanzapine versus risperidoneSANTARLASCI, Benedetta; MESSORI, Andrea.The Annals of pharmacotherapy. 2003, Vol 37, Num 4, pp 556-563, issn 1060-0280, 8 p.Article

Response of risperidone treatment may be associated with polymorphisms of HTT gene in chinese schizophrenia patientsLEI WANG; LAN YU; YUE XIAO et al.Neuroscience letters. 2007, Vol 414, Num 1, pp 1-4, issn 0304-3940, 4 p.Article

Risperidone and exaggerated hypotension during a spinal anestheticWILLIAMS, James H; HEPNER, David L.Anesthesia and analgesia. 2004, Vol 98, Num 1, pp 240-241, issn 0003-2999, 2 p.Article

Rispéridone = RisperidoneLa Revue Prescrire. 1996, Vol 16, Num 168, pp 823-825, issn 0247-7750Article

Impact clinique des neuroleptiques atypiques : étude prospective sur 6 mois en milieu hospitalier de patients traités par rispéridone ou olanzapine = Clinical impact of atypical antipsychotics: prospective 6-month study of inpatients treated by risperidone or olanzapineHAMEL, B; COURTET, P; VERGNES, C et al.Thérapie (Paris). 2001, Vol 56, Num 6, pp 645-652, issn 0040-5957, 8 p.Article

Clinical review of a long-acting, injectable formulation of risperidoneKNOX, Erin Danielle; STIMMEL, Glen L.Clinical therapeutics. 2004, Vol 26, Num 12, pp 1994-2002, issn 0149-2918, 9 p.Article

QTc interval, CYP2D6 and CYP2C9 genotypes and risperidone plasma concentrationsLIERENA, Adrian; BERECZ, Roland; DORADO, Pedro et al.Journal of psychopharmacology (Oxford). 2004, Vol 18, Num 2, pp 189-193, issn 0269-8811, 5 p.Article

Risperidone prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium currentDROLET, Benoit; YANG, Tao; DALEAU, Pascal et al.Journal of cardiovascular pharmacology. 2003, Vol 41, Num 6, pp 934-937, issn 0160-2446, 4 p.Article

Risperidone for control of agitation in dementia patientsFALSETTI, A. E.American journal of health-system pharmacy. 2000, Vol 57, Num 9, pp 862-870, issn 1079-2082Article

Switching from therapy with typical antipsychotic agents to risperidone : Long-term impact on patient outcomeMALLA, A. K; NORMAN, R. M. G; KOTTEDA, V et al.Clinical therapeutics. 1999, Vol 21, Num 5, pp 806-817, issn 0149-2918Article

Risperidone-induced photosensitivityALMOND, D. S; RHODES, L. E; PIRMOHAMED, M et al.Postgraduate medical journal. 1998, Vol 74, Num 870, pp 252-253, issn 0032-5473Article

Syndrome malin des neuroleptiques induit par la rispéridone = Risperidone-induced neuroleptic malignant syndromeROHRBACH, P; COLLINOT, J. P; VALLET, G et al.Annales françaises d'anesthésie et de réanimation. 1998, Vol 17, Num 1, pp 85-86, issn 0750-7658Article

Clinical experience with the long-acting injectable formulation of the atypical antipsychotic, risperidoneMARTIN, Stephen D; LIBRETTO, Susan E; PRATT, David J et al.Current medical research and opinion. 2003, Vol 19, Num 4, pp 298-305, issn 0300-7995, 8 p.Article

Comparative behavioural effects of typical and atypical antipsychotic drugs in rhesus monkeyKUMAR, Rakesh; PALIT, Gautam; DHAWAN, Bhola N et al.European journal of pharmacology. 2003, Vol 462, Num 1-3, pp 133-138, issn 0014-2999, 6 p.Article

Risperidone and Total 9-Hydroxyrisperidone in Relation to Prescribed Dose and Other Factors: Data From a Therapeutic Drug Monitoring Service, 2002-2010BOWSKILL, Sally V. J; HANDLEY, Simon A; FISHER, Danielle S et al.Therapeutic drug monitoring. 2012, Vol 34, Num 3, pp 349-355, issn 0163-4356, 7 p.Article

Association between a polymorphism of the HTR3A gene and therapeutic response to risperidone treatment in drug-naive Chinese schizophrenia patientsBO GU; LEI WANG; ZHANG, Ai-Ping et al.Pharmacogenetics and genomics (Print). 2008, Vol 18, Num 8, pp 721-727, issn 1744-6872, 7 p.Article

An open-label extension trial of risperidone monotherapy in the treatment of bipolar I disorderHIRSCHFELD, Robert M. A; EERDEKENS, Mariëlle; KALALI, Amir H et al.International clinical psychopharmacology. 2006, Vol 21, Num 1, pp 11-20, issn 0268-1315, 10 p.Article

Risperidone treatment of bipolar maniaNGUYEN, Lisa N; GUTHRIE, Sally K.The Annals of pharmacotherapy. 2006, Vol 40, Num 4, pp 674-682, issn 1060-0280, 9 p.Article

Serum ghrelin concentrations in patients receiving olanzapine or risperidoneTOGO, Takashi; HASEGAWA, Koichi; MIURA, Satoshi et al.Psychopharmacologia. 2004, Vol 172, Num 2, pp 230-232, issn 0033-3158, 3 p.Article

Diminished catalepsy and dopamine metabolism distinguish aripiprazole from haloperidol or risperidoneNAKAI, Satoru; HIROSE, Tsuyoshi; MOLINOFF, Perry B et al.European journal of pharmacology. 2003, Vol 472, Num 1-2, pp 89-97, issn 0014-2999, 9 p.Article

Time-dependence of risperidone and asenapine sensitization and associated D₂ receptor mechanismJUN GAO; MING LI.Behavioural brain research. 2013, Vol 257, pp 286-294, issn 0166-4328, 9 p.Article

Usefulness of long-acting injectable risperidone during 12-month maintenance therapy of bipolar disorderCHANGSU HAN; LEE, Moon-Soo; PAE, Chi-Un et al.Progress in neuro-psychopharmacology & biological psychiatry. 2007, Vol 31, Num 6, pp 1219-1223, issn 0278-5846, 5 p.Article

Efficacy of risperidone in treating the hyperactive symptoms of deliriumLIU, Chia-Yih; JUANG, Yeong-Yu; LIANG, Hsin-Yi et al.International clinical psychopharmacology. 2004, Vol 19, Num 3, pp 165-168, issn 0268-1315, 4 p.Article

Fine-tuning risperidone dosage for acutely exacerbated schizophrenia: clinical determinantsLANE, Hsien-Yuan; CHANG, Yue-Cune; CHIU, Chih-Chiang et al.Psychopharmacologia. 2004, Vol 172, Num 4, pp 393-399, issn 0033-3158, 7 p.Article